1.
Study of Lopinavir/Ritonavir in Severe COVID-19 Patients with Comorbid Hypertension and Diabetes Mellitus. Indian Journal of Forensic Medicine & Toxicology. 2022;16(4):174-181. doi:10.37506/ijfmt.v16i4.18570